尿路結石症管理デバイス市場：治療タイプ別、エンドユーザー別-2025-2030年の世界予測

尿路結石症管理デバイス市場は、2023年に5億188万米ドルと評価され、2024年には5億5,538万米ドルに達すると予測され、CAGR 10.75%で成長し、2030年には10億2,591万米ドルに達すると予測されています。

尿路結石症管理デバイス市場には、腎臓結石または尿路結石症の診断、治療、管理に使用される医療機器が含まれます。ライフスタイルの変化や食習慣に影響された腎結石の蔓延により必要性が生じ、効果的な管理ソリューションへの需要が高まっています。これらの機器は、体外衝撃波結石破砕装置、経皮的腎結石除去装置、尿管鏡など多岐にわたり、病院、診療所、外来手術センターで使用されています。主な成長要因としては、罹患率の増加、低侵襲手術の進歩、患者の意識の高まりなどが挙げられます。市場は、技術革新と有利な償還シナリオによってさらに推進され、ポータブルで正確な診断ツールの開発、インテリジェントなレーザー結石破砕術、カスタマイズされた治療計画のためのAIの統合など、有利な潜在的機会を提供しています。しかし、先進的な機器の高額なコスト、新興国市場の限られたヘルスケアインフラ、特定の処置に伴う潜在的な合併症などの要因が、普及を妨げる可能性があり、市場成長の課題となっています。運用コストの削減、精度の向上、患者の安全性の改善をターゲットとした技術革新は、大きな可能性を秘めています。ステント開発用生体材料、生分解性尿管ステント、ロボット支援手術の調査は、探求と事業成長のための魅力的な分野です。競争が激しいことから、ヘルスケアプロバイダーとの連携による統合ケアシステムや、戦略的な価格設定による新興市場への注力が、市場での存在感を高める可能性があります。地域の規制の違いを理解し、医療従事者が先進医療機器を操作するための包括的なトレーニングプログラムに投資することが不可欠です。進化し続ける市場であるため、技術動向、患者の嗜好、規制の最新情報に常に注意を払う必要があります。費用対効果を確保しながら、患者の快適性と手技の効率性を優先することが、新たな機会を生かすことにつながり、最終的には尿路結石症管理の領域における技術の進歩と市場の拡大を促進することになります。

市場力学：急速に進化する尿路結石症管理デバイス市場の主要市場インサイトを公開

尿路結石症管理デバイス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 尿路結石の発生率の増加と高齢者人口の増加
  • 非侵襲的手術への嗜好の高まりと低侵襲技術への意識の高まり
• 市場抑制要因
  • これらの機器や手術の入手可能性の制限と高コスト
• 市場機会
  • 病院部門における革新的技術の採用増加
  • 非公開会社からの投資の急増と政府の積極的な取り組み
• 市場の課題
  • 尿閉塞や腎臓周辺の出血など、治療による副作用の可能性

ポーターの5つの力：尿路結石症管理デバイス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、市場情勢の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：尿路結石症管理デバイス市場における外部からの影響の把握

外部マクロ環境要因は、尿路結石症管理デバイス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析尿路結石症管理デバイス市場における競合情勢の把握

尿路結石症管理デバイス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス尿路結石症管理デバイス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、尿路結石症管理デバイス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨尿路結石症管理デバイス市場における成功への道筋を描く

尿路結石症管理デバイス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 尿路結石の発生率増加と高齢者人口の増加
    • 非侵襲性手術への傾向の高まりと低侵襲性技術への認識
  • 抑制要因
    • これらの機器や手順は入手が限られており、コストも高い
  • 機会
    • 病院分野における革新的技術の導入増加
    • 非公開会社からの投資の急増と政府の好ましい取り組み
  • 課題
    • 治療による副作用としては、尿の詰まりや腎臓周辺の出血などが考えられます。
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 尿路結石症管理デバイス市場治療の種類別

• 体外衝撃波結石破砕術
• 体内結石破砕術
• 経皮的腎結石摘出術

第7章 尿路結石症管理デバイス市場：エンドユーザー別

• 外来手術センター
• 病院・クリニック

第8章 南北アメリカの尿路結石症管理デバイス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第9章 アジア太平洋地域の尿路結石症管理デバイス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第10章 欧州・中東・アフリカの尿路結石症管理デバイス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第11章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Advanced MedTech
• AKSM, Ltd.
• Allengers Medical Systems Ltd.
• Boston Scientific Corporation
• Cook Medical
• DirexGroup
• Dornier MedTech GmbH
• E.M.S. Electro Medical Systems S.A.
• EDAP TMS
• Karl Storz GmbH & Co. KG
• Olympus Corporation
• Richard Wolf GmbH
• Siemens Healthcare

LIST OF FIGURES

• FIGURE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET RESEARCH PROCESS
• FIGURE 2. UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 11. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 13. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 19. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. UROLITHIASIS MANAGEMENT DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. UROLITHIASIS MANAGEMENT DEVICES MARKET DYNAMICS
• TABLE 7. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY EXTRACORPOREAL SHOCK WAVE LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY INTRACORPOREAL LITHOTRIPSY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY PERCUTANEOUS NEPHROLITHOTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 15. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 16. AMERICAS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 17. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 18. ARGENTINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 19. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 20. BRAZIL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 22. CANADA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 23. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 24. MEXICO UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 26. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. UNITED STATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 28. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 30. ASIA-PACIFIC UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 32. AUSTRALIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 34. CHINA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. INDIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 38. INDONESIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 40. JAPAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. MALAYSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 44. PHILIPPINES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 46. SINGAPORE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. SOUTH KOREA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 50. TAIWAN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 52. THAILAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. VIETNAM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 55. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 56. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. EUROPE, MIDDLE EAST & AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 58. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 59. DENMARK UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 61. EGYPT UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 63. FINLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 64. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 65. FRANCE UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. GERMANY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 68. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 69. ISRAEL UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 71. ITALY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 73. NETHERLANDS UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 75. NIGERIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 76. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 77. NORWAY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 79. POLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 80. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 81. QATAR UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 83. RUSSIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 84. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 85. SAUDI ARABIA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH AFRICA UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 89. SPAIN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 91. SWEDEN UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 92. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 93. SWITZERLAND UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 95. TURKEY UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 96. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 97. UNITED ARAB EMIRATES UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
• TABLE 99. UNITED KINGDOM UROLITHIASIS MANAGEMENT DEVICES MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. UROLITHIASIS MANAGEMENT DEVICES MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 101. UROLITHIASIS MANAGEMENT DEVICES MARKET, FPNV POSITIONING MATRIX, 2023

The Urolithiasis Management Devices Market was valued at USD 501.88 million in 2023, expected to reach USD 555.38 million in 2024, and is projected to grow at a CAGR of 10.75%, to USD 1,025.91 million by 2030.

The scope of the Urolithiasis Management Devices market encompasses medical devices used for diagnosing, treating, and managing kidney stones or urolithiasis. Necessity arises due to the prevalence of kidney stones, influenced by lifestyle changes and dietary habits, driving demand for effective management solutions. These devices range from extracorporeal shock wave lithotripsy systems, percutaneous nephrolithotomy equipment, to ureteroscopes, applied in hospitals, clinics, and ambulatory surgical centers. Key growth influencers include increasing incidence rates, advancements in minimally invasive procedures, and rising patient awareness. The market is further propelled by technological innovations and favorable reimbursement scenarios, offering lucrative potential opportunities in developing portable and accurate diagnostic tools, intelligent laser lithotripsy, and integration of AI for customized treatment plans. However, market growth is challenged by factors such as high costs of advanced devices, limited healthcare infrastructure in developing regions, and potential complications associated with certain procedures which may hinder widespread adoption. Innovations targeting reduced operational costs, enhanced precision, and improved patient safety hold significant promise. Research in biomaterials for stent development, biodegradable ureteral stents, and robotic-assisted surgeries represent enticing areas for exploration and business growth. Given the highly competitive nature, collaborations with healthcare providers for integrated care systems and focusing on emerging markets with strategic pricing may enhance market presence. Understanding regional regulatory variances and investing in comprehensive training programs for healthcare professionals to operate advanced devices are essential. The evolving nature of the market demands continuous vigilance on technological trends, patient preferences, and regulatory updates. Prioritizing patient comfort and procedural efficiency while ensuring cost-effectiveness will aid in capitalizing on emerging opportunities, ultimately driving technological advancements and market expansion in the realm of urolithiasis management.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urolithiasis Management Devices Market

The Urolithiasis Management Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Growing incidence of urinary stones and increasing elderly population
  • Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
• Market Restraints
  • Limited availability and high cost of these devices and procedure
• Market Opportunities
  • Increasing adoption of innovative technologies in the hospital sector
  • Surge in investment from private companies and favorable government initiatives
• Market Challenges
  • Probable side effects of the treatment such as blockage of urine and bleeding around kidneys

Porter's Five Forces: A Strategic Tool for Navigating the Urolithiasis Management Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urolithiasis Management Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urolithiasis Management Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urolithiasis Management Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urolithiasis Management Devices Market

A detailed market share analysis in the Urolithiasis Management Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urolithiasis Management Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urolithiasis Management Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urolithiasis Management Devices Market

A strategic analysis of the Urolithiasis Management Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urolithiasis Management Devices Market, highlighting leading vendors and their innovative profiles. These include Advanced MedTech, AKSM, Ltd., Allengers Medical Systems Ltd., Boston Scientific Corporation, Cook Medical, DirexGroup, Dornier MedTech GmbH, E.M.S. Electro Medical Systems S.A., EDAP TMS, Karl Storz GmbH & Co. KG, Olympus Corporation, Richard Wolf GmbH, and Siemens Healthcare.

Market Segmentation & Coverage

This research report categorizes the Urolithiasis Management Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment Type, market is studied across Extracorporeal Shock Wave Lithotripsy, Intracorporeal Lithotripsy, and Percutaneous Nephrolithotomy.
• Based on End-User, market is studied across Ambulatory Surgical Centers and Hospitals & Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing incidence of urinary stones and increasing elderly population
    • 5.1.1.2. Rising proclivity for non-invasive surgeries and awareness of minimally invasive techniques
  • 5.1.2. Restraints
    • 5.1.2.1. Limited availability and high cost of these devices and procedure
  • 5.1.3. Opportunities
    • 5.1.3.1. Increasing adoption of innovative technologies in the hospital sector
    • 5.1.3.2. Surge in investment from private companies and favorable government initiatives
  • 5.1.4. Challenges
    • 5.1.4.1. Probable side effects of the treatment such as blockage of urine and bleeding around kidneys
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Urolithiasis Management Devices Market, by Treatment Type

• 6.1. Introduction
• 6.2. Extracorporeal Shock Wave Lithotripsy
• 6.3. Intracorporeal Lithotripsy
• 6.4. Percutaneous Nephrolithotomy

7. Urolithiasis Management Devices Market, by End-User

• 7.1. Introduction
• 7.2. Ambulatory Surgical Centers
• 7.3. Hospitals & Clinics

8. Americas Urolithiasis Management Devices Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Urolithiasis Management Devices Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Urolithiasis Management Devices Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Advanced MedTech
• 2. AKSM, Ltd.
• 3. Allengers Medical Systems Ltd.
• 4. Boston Scientific Corporation
• 5. Cook Medical
• 6. DirexGroup
• 7. Dornier MedTech GmbH
• 8. E.M.S. Electro Medical Systems S.A.
• 9. EDAP TMS
• 10. Karl Storz GmbH & Co. KG
• 11. Olympus Corporation
• 12. Richard Wolf GmbH
• 13. Siemens Healthcare